SCHEMBL7872690

SCHEMBL7872690

COC(=O)c1oc2ncccc2c1N

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.60
ALDH1A1 P00352 8/20 0.48
HPGD P15428 5/20 0.48
HSD17B10 Q99714 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HTT P42858 2/20 0.48
TP53 P04637 2/20 0.48
MAP2K1 Q02750 1/20 0.44
AHR P35869 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 3/20 0.39
ALOX15 P16050 2/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
ATM Q13315 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29730728 0.85 KDM4E (0.63) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL259266 0.85 KDM4E (0.63) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL31278207 0.84 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2HTTTP53
SCHEMBL30731205 0.82 MAP2K1 (0.44) KDM4EALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL259242 0.79 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10HTT
SCHEMBL20361090 0.77 KDM4E (0.60) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL2950634 0.77 KDM4E (0.60) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL8242334 0.76 PRKCI (0.52) KDM4EALDH1A1HPGDHTTMEN1
SCHEMBL1885241 0.75 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL4851465 0.75 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116390-A1 PYRIMIDINE-2(1H)-ONE-FUSED BICYCLIC COMPOUND HAVING MAT2A INHIBITORY ACTIVITY AND USE THEREOF 上海海和药物研究开发股份有限公司 2023-06-29 WO disclosed
WO-2010120987-A1 RING FUSED, UREIDOARYL- AND CARBAMOYLARYL-BRIDGED MORPHOLINO-PYRIMIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH LLC (US) 2010-10-21 WO disclosed
EP-0808318-B1 TRICYCLIC SUBSTITUTED HEXAHYDROBENZ[E]ISOINDOLE ALPHA-1 ADRENERGIC ANTAGONISTS ABBOTT LAB (US) 2000-06-28 EP disclosed
US-5597823-A TREATING BENIGN PROSTATIC HYPERPLASIA ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
WO-1996022992-A1 TRICYCLIC SUBSTITUTED HEXAHYDROBENZ[E]ISOINDOLE ALPHA-1 ADRENERGIC ANTAGONISTS ABBOTT LABORATORIES (US) 1996-08-01 WO disclosed